Literature DB >> 11551926

Definition of a dioxin receptor mutant that is a constitutive activator of transcription: delineation of overlapping repression and ligand binding functions within the PAS domain.

J McGuire1, K Okamoto, M L Whitelaw, H Tanaka, L Poellinger.   

Abstract

The intracellular dioxin (aryl hydrocarbon) receptor is a ligand-activated transcription factor that mediates the adaptive and toxic responses to environmental pollutants such as 2,3,7,8-tetrachlorodibenzo-p-dioxin and structurally related congeners. Whereas the ligand-free receptor is characterized by its association with the molecular chaperone hsp90, exposure to ligand initiates a multistep activation process involving nuclear translocation, dissociation from the hsp90 complex, and dimerization with its partner protein Arnt. In this study, we have characterized a dioxin receptor deletion mutant lacking the minimal ligand-binding domain of the receptor. This mutant did not bind ligand and localized constitutively to the nucleus. However, this protein was functionally inert since it failed to dimerize with Arnt and to bind DNA. In contrast, a dioxin receptor deletion mutant lacking the minimal PAS B motif but maintaining the N-terminal half of the ligand-binding domain showed constitutive dimerization with Arnt, bound DNA, and activated transcription in a ligand-independent manner. Interestingly, this mutant showed a more potent functional activity than the dioxin-activated wild-type receptor in several different cell lines. In conclusion, the constitutively active dioxin receptor may provide an important mechanistic tool to investigate receptor-mediated regulatory pathways in closer detail.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11551926     DOI: 10.1074/jbc.M105607200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  Structural and functional characterization of the aryl hydrocarbon receptor ligand binding domain by homology modeling and mutational analysis.

Authors:  Alessandro Pandini; Michael S Denison; Yujuan Song; Anatoly A Soshilov; Laura Bonati
Journal:  Biochemistry       Date:  2007-01-23       Impact factor: 3.162

2.  The LMP1 promoter can be transactivated directly by NF-kappaB.

Authors:  Constantinos Demetriades; George Mosialos
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

3.  Role of the Per/Arnt/Sim domains in ligand-dependent transformation of the aryl hydrocarbon receptor.

Authors:  Anatoly Soshilov; Michael S Denison
Journal:  J Biol Chem       Date:  2008-09-19       Impact factor: 5.157

4.  Omeprazole Inhibits Pancreatic Cancer Cell Invasion through a Nongenomic Aryl Hydrocarbon Receptor Pathway.

Authors:  Un-Ho Jin; Sang-Bae Kim; Stephen Safe
Journal:  Chem Res Toxicol       Date:  2015-04-09       Impact factor: 3.739

5.  Malignant transformation of mammary epithelial cells by ectopic overexpression of the aryl hydrocarbon receptor.

Authors:  J Brooks; S E Eltom
Journal:  Curr Cancer Drug Targets       Date:  2011-06       Impact factor: 3.428

6.  Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells.

Authors:  Anthony E Boitano; Jian Wang; Russell Romeo; Laure C Bouchez; Albert E Parker; Sue E Sutton; John R Walker; Colin A Flaveny; Gary H Perdew; Michael S Denison; Peter G Schultz; Michael P Cooke
Journal:  Science       Date:  2010-08-05       Impact factor: 47.728

7.  The Aryl Hydrocarbon Receptor Preferentially Marks and Promotes Gut Regulatory T Cells.

Authors:  Jian Ye; Ju Qiu; John W Bostick; Aki Ueda; Hilde Schjerven; Shiyang Li; Christian Jobin; Zong-Ming E Chen; Liang Zhou
Journal:  Cell Rep       Date:  2017-11-21       Impact factor: 9.423

8.  Dioxin receptor expression inhibits basal and transforming growth factor β-induced epithelial-to-mesenchymal transition.

Authors:  Eva M Rico-Leo; Alberto Alvarez-Barrientos; Pedro M Fernandez-Salguero
Journal:  J Biol Chem       Date:  2013-02-04       Impact factor: 5.157

9.  Anthracycline inhibits recruitment of hypoxia-inducible transcription factors and suppresses tumor cell migration and cardiac angiogenic response in the host.

Authors:  Tetsuhiro Tanaka; Junna Yamaguchi; Kumi Shoji; Masaomi Nangaku
Journal:  J Biol Chem       Date:  2012-08-20       Impact factor: 5.157

10.  A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors.

Authors:  Patrik Andersson; Jacqueline McGuire; Carlos Rubio; Katarina Gradin; Murray L Whitelaw; Sven Pettersson; Annika Hanberg; Lorenz Poellinger
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.